Adenosine A3 receptor stimulation and cerebral ischemia
- PMID: 7821362
- PMCID: PMC3426360
- DOI: 10.1016/0014-2999(94)90523-1
Adenosine A3 receptor stimulation and cerebral ischemia
Abstract
Chronic treatment with the selective adenosine A3 receptor agonist N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide (IB-MECA) administered prior to either 10 or 20 min forebrain ischemia in gerbils resulted in improved postischemic cerebral blood circulation, survival, and neuronal preservation. Opposite effects, i.e., impaired postischemic blood flow, enhanced mortality, and extensive neuronal destruction in the hippocampus were seen when IB-MECA was given acutely. Neither adenosine A1 nor A2 receptors are involved in these actions. The data indicate that stimulation of adenosine A3 receptors may play an important role in the development of ischemic damage, and that adenosine A3 receptors may offer a new target for therapeutic interventions.
Figures
References
-
- Abbracchio MP, Fogliatto G, Paoletti AM, Rovati GE, Cattabeni F. Prolonged in vitro exposure of rat brain slices to adenosine analogues: selective desensitization of adenosine A1 but not A2 receptors. Eur. J. Pharmacol. Mol. Pharmacol. 1992;227:317. - PubMed
-
- Ali H, Cunha-Melo JR, Saul WF, Beaven MA. Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen stimulated RBL-2H3 cells. Evidence for a novel adenosine receptor. J. Biol. Chem. 1990;15:745. - PubMed
-
- Bantue-Ferrer B, Decombe R, Reymann JM, Schgatz C, Allain H. Progress in understanding the pathophysiology of cerebral isehemia: the almitrine-raubasine approach. Clin. Neuropharmacol. 1990;13(Suppl. 3):S9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
